FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Described is matrix layer, suitable for application in plaster for transdermal delivery, aimed at introduction of biologically active compounds, which includes phosphate compound of tocopherol and polymer carrier. Also described is transdermal plaster and method of its production.
EFFECT: plaster makes it possible to efficiency introduce biologically active compounds.
48 cl, 15 tbl, 13 dwg, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CARRIER COMPOSITION | 2010 |
|
RU2577233C2 |
| TRANSDERMAL SYSTEM FOR VARENICLINE | 2006 |
|
RU2388461C2 |
| TRANSDERMAL DELIVERY OF LAZOPHOXIPHEN | 2001 |
|
RU2328276C2 |
| TRANSDERMAL PHARMACEUTICAL PREPARATION AND ADMINISTERING TIROFIBAN | 2010 |
|
RU2539398C2 |
| TRANSPORTING FILLER, WHICH CONTAINS ONE OR MORE DI- AND/OR MONO-(ELECTRONIC TRANSMITTING AGENT) PHOSPHATE DERIVATIVES OR THEIR COMPOUNDS | 2006 |
|
RU2434643C2 |
| GLUES BASED ON SILICON-ACRYL HYBRID POLYMER | 2010 |
|
RU2544702C2 |
| HYDROPHILIC BIOLOGICALLY COMPATIBLE ADHESIVE COMPOSITIONS AND APPLICATION THEREOF | 2006 |
|
RU2411045C2 |
| METHOD AND IMPROVED PHARMACEUTICAL COMPOSITION FOR ACCELERATING THE TRANSDERMAL DELIVERY OF A PDE-5 INHIBITOR | 2016 |
|
RU2660353C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM WITH HIGH LEVEL OF USING ACTIVE SUBSTANCE AND DOSE ACCURACY | 2007 |
|
RU2454994C2 |
| METHOD AND IMPROVED PHARMACEUTICAL COMPOSITION FOR ACCELERATION OF PDE-5 INHIBITOR TRANSDERMAL DELIVERY | 2011 |
|
RU2618462C2 |
